HLB New Liver Cancer Drug Full Review Begins (HLB 간암 신약 본심사 개시)Compare →
Last 30 days: first seen Nov 4 · 0.3h on the board · best rank #7
- Daum 100%
Picked up by Daum only — may be platform-internal dynamics.
Sample — 1 cross-checked sources · 3 snapshots (5-min interval)
Not on the board right now — here's the record of when it was.
«HLB 간암 신약 본심사 개시» first surfaced on November 4, 2026, held the board for 0.3h over the last 30 days, peaking at #7. The driver: “HLB, New Liver Cancer Drug FDA Begins Full Review - Money Today”. Currently off the board.
Why it's trending
HLB, New Liver Cancer Drug FDA Begins Full Review - Money Today— Money Today
This is an actual headline, quoted as-is — never summarized or generated.
Related video
HLB 간암 신약 본심사 개시
HLB, 간암 신약 FDA 문턱서 좌절…효능·안전성 문제 아니다
A YouTube video found by searching this keyword.
Related coverage
·
HLB 간암 신약 본심사 개시 first appeared on KoreaTrendBoard on November 4, 2026. It has been observed 3 times since, peaking at rank 7 with a score of 25.0. It was last seen on November 4, 2026.
Rose alongside
Times they appeared on the same board snapshot in the last 7 days. Three or more only — once or twice is chance.
Loading
This chart shows the last 14 days. Pro opens 180 days and lets you export the same data as CSV — one row per day with rank, score and source count. See what opens →
Rose alongside
The number is how many times it appeared on the board at the same moment as this keyword, over the last 7 days.
The full board on 2026-11-04 → · This week · Glossary
Picked up by: DaumReferenced from each site's publicly available rankings. No affiliation or partnership.
Want a heads-up when «HLB 간암 신약 본심사 개시» climbs again? It's free.
No signup form — your email is the account. One click to stop.
- 180-day history — the curve, not the moment
- Alerts — pinged within 5 minutes when your keyword moves
- API — ranks and scores straight into your report